日本分子腫瘍マーカー研究会誌
Online ISSN : 2433-8575
キメラ抗体Nd2のADCC活性誘導を応用した膵癌ターゲッティング療法
玉森 豊澤田 鉄二西原 承浩山本 篤山下 好人八代 正和山田 靖哉仲田 文造大平 雅一西野 裕二平川 弘聖
著者情報
ジャーナル フリー

2001 年 16 巻 p. 10-11

詳細
抄録
Nd2 is murine monoclonal antibody derived from purified mucin of human pancreatic cancer cell line SW1990. We prepared mouse/human chimeric antibody Nd2(cNd2) and reported that cNd2 could induce antibody dependent cell-mediated cytotoxicity(ADCC) in vitro. In this study, we investigated the effect of cNd2 in nude mouse, and the enhancement of ADCC of cNd2 by IL-2 stimulated lymphocytes in vitro. In nude mouse, intraperitoneal injection of cNd2 inhibited the tumor growth in xenografted model, elongated the survival in orthotopically transplanted model, and suppressed the number of liver metastasis in spleno-injected model. In vitro study, IL-2 enhanced ADCC of cNd2.
著者関連情報
© 2001 日本分子腫瘍マーカー研究会
前の記事 次の記事
feedback
Top